Viewing StudyNCT04334993



Ignite Creation Date: 2024-05-06 @ 2:30 PM
Last Modification Date: 2024-10-26 @ 1:32 PM
Study NCT ID: NCT04334993
Status: RECRUITING
Last Update Posted: 2021-05-07
First Post: 2020-03-31

Brief Title: Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study
Sponsor: Israeli Medical Association
Organization: Israeli Medical Association

Conditions & Keywords Data

Conditions:
Name
High-Risk Cancer
Philadelphia-Negative ALL
Keywords:
Name View
Philadelphia-Negative ALL View
Pediatric therapy View
Blinatumomab View
Allogeneic transplantation View